LivaNova PLC Deferred Tax Assets, Valuation Allowance
LivaNova PLC (LIVN) had Deferred Tax Assets, Valuation Allowance of $127.59 million as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2026-02-25
- 2025-12-31: Deferred Tax Assets, Valuation Allowance $127.59M.
- 2024-12-31: Deferred Tax Assets, Valuation Allowance $158.82M.
- 2023-12-31: Deferred Tax Assets, Valuation Allowance $182.46M.
- 2022-12-31: Deferred Tax Assets, Valuation Allowance $264.75M.
| Period end | Deferred Tax Assets, Valuation Allowance | Deferred Tax Assets, Valuation Allowance as first filed |
|---|---|---|
| 2025-12-31 | $127.59M 10-K · filed 2026-02-25 | |
| 2024-12-31 | $158.82M 10-K · filed 2026-02-25 | |
| 2023-12-31 | $182.46M 10-K · filed 2025-02-25 | |
| 2022-12-31 | $264.75M 10-K · filed 2024-02-29 | |
| 2018-12-31 | $40.26M 10-K · filed 2019-03-18 | |
| 2017-12-31 | $93.33M 10-K · filed 2019-03-18 | |
| 2016-12-31 | $36.28M 10-K · filed 2018-02-28 | $51.50M 10-K · filed 2017-03-01 |
| 2015-12-31 | $50.12M 10-K · filed 2017-03-01 | |
| 2015-10-18 | $2.40M 10-Q · filed 2015-12-08 | |
| 2015-04-24 | $1.61M 10-K · filed 2017-03-01 | $1.61M 10-Q · filed 2015-12-02 |
| 2014-04-25 | $1.87M 10-KT · filed 2016-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |